News - Tarceva, Markets & Marketing

Filter

Popular Filters

Turkey's NSCLC drug market forecast to expand at 7% a year through 2017

13-06-2013

From 2012 to 2017, the non-small-cell lung cancer (NSCLC) market in Turkey will increase at an annual…

AlimtaBiotechnologyEli LillyEuropeMarkets & MarketingOncologyPharmaceuticalRocheTarceva

75% of US oncologists prescribe Pfizer's Xalkori just 10 months after the drug's launch

21-06-2012

US oncologists surveyed by advisory firm Decision Resources say they prescribe drugs behemoth Pfizer's…

GlaxoSmithKlineHerceptinMarkets & MarketingNorth AmericaOncologyPfizerPharmaceuticalResearchRocheTarcevaTykerbXalkori

European oncologists indicate Tarceva will threaten market position of Iressa in mutated EGFR NSCLC

02-11-2011

According to the majority of surveyed oncologists in the European Union 5 (France, Germany, Italy, Spain…

AstraZenecaEuropeIressaMarkets & MarketingOncologyPharmaceuticalRocheTarceva

Back to top